All Stories

  1. The Efficacy of Antihypertensive Drugs and miR-632 Inhibition on Parietal Remodeling in a Model of Marfan Thoracic Aortic Aneurysm
  2. Hemodynamics‐guided treatment of hypertensive disorders of pregnancy: systematic review and meta‐analysis
  3. Physical exercise improves cardiovascular function after preeclampsia and reduces the risk of recurrent preeclampsia in the subsequent pregnancy: an echocardiographic prospective cohort study
  4. Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology
  5. Umbilical venous flow and maternal hemodynamics as predictors of impaired fetal growth in gestational diabetes: a prospective study
  6. The impact of maternal cardiovascular status prior to labor on birth outcomes: an observational study
  7. Individualized maternal positioning to optimize cardiac output and placental perfusion
  8. ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction
  9. Maternal hemodynamics in early and late fetal growth restriction
  10. Definition, identification, implications and management of hypodynamic hypertension in pregnancy
  11. Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction
  12. Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications?
  13. Erratum: Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine
  14. Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine
  15. NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation
  16. Longitudinal hemodynamic evaluation of uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy
  17. The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction
  18. Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies
  19. Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM)
  20. Systemic vascular resistance may influence the outcome of in vitro fertilization
  21. Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction
  22. Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics
  23. Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction
  24. Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study
  25. Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure
  26. Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind?
  27. Friendly help for clinical use of maternal hemodynamics
  28. OC10.05: The “Valensise Radar” to understand the maternal hemodynamic status
  29. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  30. Prevention and Treatment of Fetal Growth Restriction by Influencing Maternal Hemodynamics and Blood Volume
  31. Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True?
  32. Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  33. Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth
  34. Maternal hemodynamics early in labor: a possible link with obstetric risk?
  35. Functional testing in pregnancy
  36. Screening for pre‐eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non‐obese patients
  37. Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders
  38. Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics
  39. Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy?
  40. A5. Bed rest reduces maternal total vascular resistance and enhances fetal growth
  41. D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients
  42. F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy?
  43. G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles
  44. G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia
  45. H1. Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent pre-eclampsia
  46. Persistent Maternal Cardiac Dysfunction After Preeclampsia Identifies Patients at Risk for Recurrent Preeclampsia
  47. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia
  48. PRE-ECLAMPSIA: ONE NAME, TWO CONDITIONS – THE CASE FOR EARLY AND LATE DISEASE BEING DIFFERENT
  49. Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications
  50. Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: relationship to placenta-related complications of pregnancy
  51. OC14.06: NO donors and volume expansion added to antihypertensive therapy in gestational hypertension decreases systemic vascular resistance and complications
  52. Early and Late Preeclampsia
  53. OP11.10: Maternal myocardial function in asymptomatic 24 weeks' bilateral notching women
  54. Total Vascular Resistance and Left Ventricular Morphology as Screening Tools for Complications in Pregnancy
  55. Fetal growth restriction and maternal cardiac function
  56. OC216: Treatment with NO donor patches in asymptomatic women with bilateral notch and elevated total vascular resistance
  57. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery
  58. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension
  59. P10.19: Intrauterine growth restriction and fetal body composition
  60. P10.05: Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension
  61. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome
  62. P05.28: Can we improve fetal growth acting on maternal cardiac function? A pilot study
  63. Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction
  64. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies
  65. MATERNAL CARDIOVASCULAR HAEMODYNAMICS IN NORMAL AND COMPLICATED PREGNANCIES
  66. Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women
  67. Left Ventricular Concentric Geometry as a Risk Factor in Gestational Hypertension
  68. Nifedipine-induced changes in body composition in hypertensive patients at term
  69. Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function
  70. P217: Does nifedipine improve placental function and fetal growth?
  71. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction
  72. C-peptide and insulin levels at 24–30 weeks’ gestation: an increased risk of adverse pregnancy outcomes?
  73. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study
  74. Maternal Diastolic Dysfunction and Left Ventricular Geometry in Gestational Hypertension
  75. WS12-03Uteroplacental resistances and maternal cardiac function in normal and hypertensive pregnancy: a Doppler and echocardiographic study
  76. Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study
  77. Cardiac Function
  78. Cardiac Dysfunction in Hypertensive Pregnancy